交易 Ironwood Pharmaceuticals Inc - IRWD 差价合约

Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) is a biopharmaceutical company specializing in the development and commercialization of treatments for gastrointestinal (GI) diseases. Best known for its leading drug, LINZESS®, which treats irritable bowel syndrome and chronic constipation, the company focuses on advancing innovative GI therapies. Through continued research and strategic partnerships, Ironwood remains dedicated to improving patient outcomes in gastroenterology.